Stock CNTB CONNECT BIOPHARMA HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Connect Biopharma Holdings Limited

Equities

CNTB

US2075231017

Market Closed - Nasdaq
Other stock markets
 21:30:00 26/04/2024 BST 		5-day change 1st Jan Change
1.34 USD -1.47% Intraday chart for Connect Biopharma Holdings Limited -12.99% +13.56%
04-17 Sector Update: Health Care Stocks Retreating Late Afternoon MT
04-17 Sector Update: Health Care MT

Evolution of the average Target Price on Connect Biopharma Holdings Limited

Price target over the last 5 years

History of analyst recommendation changes

21d0a.BIwqTlGxbg3vCgBiec3V9xmTOfKP9X8EBw5rZnALz0o.bNVTeBb8HUuGY181HY-WvXTid567vFJHQGEFUh45igZvwGQBO4ZYSLtzVQ~9c913f968e976e9790e45ee1ade5ec43

Analyst Recommendations on Connect Biopharma Holdings Limited

Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer MT
HC Wainwright Adjusts Price Target on Connect Biopharma Holdings to $8 From $7, Maintains Buy Rating MT
HC Wainwright Starts Coverage on Connect Biopharma With Buy Rating, $7 Price Target MT
SVB Securities Adjusts Connect Biopharma Price Target to $7 From $9, Maintains Outperform Rating MT
Piper Sandler Adjusts Price Target on Connect Biopharma Holdings to $1.75 From $1.50, Maintains Neutral Rating MT
Cantor Fitzgerald Starts Connect Biopharma Holdings at Overweight With $5 Price Target MT
Piper Sandler Downgrades Connect Biopharma Holdings to Neutral From Overweight, Adjusts Price Target to $1.50 From $25 MT
SVB Leerink Adjusts Connect Biopharma Holdings' Price Target to $9 from $22, Keeps Outperform Rating MT
Wall Street Set for Higher Open Ahead of Fed Funds Rate Announcement, ISM's Services Index MT
SVB Leerink Adjusts Connect Biopharma Holdings' Price Target to $22 from $32, Keeps Outperform Rating MT
Piper Sandler Adjusts Price Target on Connect Biopharma Holdings to $25 From $31, Reiterates Overweight Rating MT
CONNECT BIOPHARMA : CICC Starts Connect Biopharma Holdings at Outperform with $27 Price Target MT
CONNECT BIOPHARMA : SVB Leerink Initiates Coverage on Connect Biopharma Holdings Limited With Outperform Rating, $32 PT MT
CONNECT BIOPHARMA : Piper Sandler Starts Connect Biopharma Holdings at Overweight With $30 Price Target MT
CONNECT BIOPHARMA : Jefferies Starts Connect Biopharma Holdings at Buy With $27 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.34 USD
Average target price
7 USD
Spread / Average Target
+422.39%
High Price Target
8 USD
Spread / Highest target
+497.01%
Low Price Target
6 USD
Spread / Lowest Target
+347.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Connect Biopharma Holdings Limited

HC Wainwright
SVB Securities LLC
Piper Sandler
Cantor Fitzgerald
SVB Leerink
CICC Research
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CNTB Stock
  4. Consensus Connect Biopharma Holdings Limited